Category Archives: Biotechnology

biotechnology videos Biotechnology Videos On Genetic Engineering and Biotechnology Project by http://www.whatisthebiotechnology.com/ By: whatisthebiotechnology.com … Continue reading →

Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy. Published in the current issue of the journal Regenerative Medicine, the paper is based on the June 2013 U.S. Supreme Court ruling in the case Association for Molecular Pathology (AMP) v. Myriad Genetics that naturally occurring genes are unpatentable. The court case and rulings garnered discussion in the public about patenting biological materials. "The AMP v. Myriad Genetics case raises questions about the patent system," said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development. She co-authored the paper with Maude Rowland Cuchiara, the Baker Institute scholar for science and technology policy. The paper has timely significance in light of President Barack Obama's recent announcements on reforming the nation's patent process, including an initiative announced in February to "crowdsource" the review of patents. "There are not many opportunities to challenge patents once they have been granted, and the options that are available are costly and mostly limited to lawsuits," Matthews said. Judges typically … Continue reading →

Bharat Book Presents : Biotechnology Equipment Markets in China To know more please visit : https://www.bharatbook.com/Biotechnology-market-research-reports-343595/Biotechnology-Equipment-Markets-in-China.html. China's de... By: Bharat Book … Continue reading →

Biotechnology is so cool An introduction to the use of Biotechnology for medicinal production. By: Christine Paine … Continue reading →

PUBLIC RELEASE DATE: 22-Apr-2014 Contact: Jeff Falk jfalk@rice.edu 713-348-6775 Rice University HOUSTON (April 22, 2014) Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy. Published in the current issue of the journal Regenerative Medicine, the paper is based on the June 2013 U.S. Supreme Court ruling in the case Association for Molecular Pathology (AMP) v. Myriad Genetics that naturally occurring genes are unpatentable. The court case and rulings garnered discussion in the public about patenting biological materials. "The AMP v. Myriad Genetics case raises questions about the patent system," said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development. She co-authored the paper with Maude Rowland Cuchiara, the Baker Institute scholar for science and technology policy. The paper has timely significance in light of President Barack Obama's recent announcements on reforming the nation's patent process, including an initiative announced in February to "crowdsource" the review of patents. "There are not many opportunities to challenge patents once they have been granted, and the … Continue reading →

Valencia, Spain (PRWEB) April 21, 2014 Talking about the event Dr. Srinubabu Gedela, CEO and Managing Director, OMICS Group International said that Biotechnology-2014 will gather renowned researchers and decision makers both from academia and industry around the globe, to discuss on the theme Meeting the Needs of a Changing World. Biotechnology-2014 international life science conference will have Keynote presentation by eminent speakers like: Prof. Marc Van Montagu of University of Gent, Belgium (World Food Prize Laureate-2013), Prof. Ramon Serrano from Polytechnic University of Valencia-CSIC, Spain, Prof. Roberto Gaxiola of Arizona State University, USA, Prof. Alain Goossens of University of Gent, Belgium, Prof. Manuel Perez-Alonso of Instituto de MedicinaGenomica, Spain, and Dr. Mukesh Verma from National Institute of Health, USA. OMICS Group 5th World congress on Biotechnology will be organizing a National Workshop on DNA Testing in food safety at Scientific Park of Valencia University, May 27, 2014, Valencia, Spain in association with Life Technologies and Imegen. This National Workshop is chaired by experts like: Gonalo Carvalho, Thermo Fisher (Life Technologies brand), Dr. Ana Martnez-Hortigela, Imegen, Spain, Franois Bourdichon, Corporate Food Safety, Barry Callebaut, Belgium, Dr. Jose Juan Rodriguez Jerez, Universidad Autnoma de Barcelona, Spain and Dr. Ir Olivier Fumire, EURL-AP … Continue reading →

By Estel Grace Masangkay Dutch biotechnology company Mucosis B.V. announced that it has entered into a strategic, long-term collaboration and license agreement with China-based Changchun BCHT Biotechnology Co (BCHT). Mucosis also reported that it has raised 5 million in a new financing round. Under the terms of the new agreement, Mucosis will receive an equity investment along with customary payments. This includes royalties for the licensing of its SynGEM prefusion F vaccine candidate for prophylaxis of respiratory synctial virus (RSV). Mucosis Mimopath platform will also be licensed for other disease targets within the Peoples Republic of China on an exclusive basis and non-exclusively in other countries within Asia. Dr Kong, President of Changchun BCHT Biotechnology Co., said, We are delighted to form this strategic partnership with Mucosis BV to advance the RSV SynGEM vaccine program and develop other vaccine candidates based on the validated Mimopath platform technology. I believe this business relationship between our two companies will strengthen our pipeline of new vaccine products. Changchun BCHT Biotechnology is a 600-person biopharmaceutical enterprise based in China and focused on R&D, production, and commercialization of vaccines, peptide drugs, and biologics. Thomas Johnston, CEO of Mucosis, said, We are pleased with BCHT joining … Continue reading →

Drug manufacture and Biotechnology'14 - SCOPS - final phase ( Auditing ) final phase (formuman) applying QC regulations and assessment by Auditing. By: Drug Manufacturing Workshop SCOPS … Continue reading →

France protests new EU approved genetically modified corn ScienceDaily France's Greenpeace activists drape the Eiffel Tower's fields in giant genetically modified corn to protest EU ministers' recent approval of the controversia... By: Biotechnology Videos … Continue reading →

Biotechnology in Action (Arizona) This video is a compilation of items I produced at and after Biotech University held in Phoenix, Ariz. on March 28. Special thanks to: Alison Van Eenennaam, ... By: Amanda Gee … Continue reading →